DEXWireNews

E.L.F. Beauty (NYSE: $ELF) Jumped 22% on Q1 Earnings Results

BATS:ELF   e.l.f. Beauty, Inc.
Cosmetics company e.l.f. Beauty (NYSE: ELF ) reported first-quarter earnings results that surpassed analysts' EPS expectations and revenue by 71% YoY. The company surpassed the 1B annual sales milestone in FY'24, but its operating margin missed analysts' expectations and its full-year revenue and earnings guidance missed Wall Street's estimates. ELF Beauty provided conservative guidance partly due to concerns about macro uncertainty, with the FY'25 sales forecast implying 21.1% growth.

Analysts at William Blair and Bank of America highlighted a "meaningful" Q4 sales beat, viewing guidance for fiscal 2025 as likely conservative due to disciplined management and strong sales quarter to date. Total sales growth of 71% was driven by volume (up 50%) and price/mix (higher by 21%) and was broad based across categories (cosmetics, skin care) and channels (national retailers and digital).

ELF Beauty ( ELF ) forecasted EPS of $3.20-$3.25 in fiscal 2025, rising from $3.18 in fiscal 2024. The company guided revenue of $1.23 billion-$1.25 billion, also below views but up from $1.024 billion in fiscal 2024. ELF Beauty's fiscal year ends in March.

Shares of the cosmetics company rocketed 18.8%, reaching 184.64 in big volume on the stock market today. ELF Beauty stock ( ELF ) recovered the 50-day line for the first time since a broad beauty stock sell-off in April. The Relative Strength Index (RSI) which sits at 61.53 also bolted higher Thursday after lagging since March. Target issued a reassuring note on beauty sales while issuing a glum earnings report, stating shoppers bought beauty items but less of other discretionary items, such as apparel and home products.

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our Mobile App >> link-to.app/dexwirenews

2) Join our Telegram >> t.me/DEXWireNews

3) Join us on WhatsApp >> dexwirenews.com/WhatsApp

4) Follow @DEXWireNews on Social Media
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.